Comparable stake leader
STROME MEZZANINE FUND, LP
SEC ownership of Zivo Bioscience, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001101026.
Disclosed value leader
Laith L. Yaldoo
Comparable rows
2/13
Latest evidence
17 Apr 2026
- Public ticker
- ZIVO, ZIVOW on OTC
- Parsed ownership sources
-
13D/G, 3/4/5, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
STROME MEZZANINE FUND, LP
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
2 of 13
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
STROME MEZZANINE FUND, LP
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
17 Apr 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001101026
- Issuer location
- Bloomfield Hills, MI
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Zivo Bioscience, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
STROME MEZZANINE FUND, LP
Disclosed value leader
Laith L. Yaldoo
Comparable rows
2/13
Latest evidence
17 Apr 2026
13D/G
3/4/5
13F
Lead comparable stake: 12%
11 rows are not safely comparable across share classes.
13D/G row: STROME MEZZANINE FUND, LP
Showing 1-8 of 13 holder rows.
Quick read
STROME MEZZANINE FUND, LP leads the comparable SEC ownership view at 12%.
2 of 13 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens STROME MEZZANINE FUND, LP's linked filing trail.
Comparable ownership
Top 2
STROME MEZZANINE FUND, LP
12%
Mark E. Strome
12%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 13 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| STROME MEZZANINE FUND, LP |
13D/G
Mark E. Strome
|
12%
|
$53,142
442,854 shares
|
$0 | 26 Dec 2024 |
| Mark E. Strome |
3/4/5
13D/G
10%+ Owner
|
12%
from 13D/G
|
$1,145,884
618,013 shares
mixed-class rows
|
+$645,396 | 17 Apr 2026 |
| Laith L. Yaldoo |
3/4/5
Director, 10%+ Owner
|
—
mixed-class rows
|
$5,687,168
584,889 shares
mixed-class rows
|
+$344,971 | 27 Feb 2026 |
| Christopher D. Maggiore |
3/4/5
Director, 10%+ Owner
|
—
mixed-class rows
|
$4,419,754
520,367 shares
mixed-class rows
|
+$299,414 | 14 Jan 2026 |
| STROME GROUP, INC. |
3/4/5
Affiliate of 10% Owner
|
—
class O/S missing
|
$1,145,884
572,942 shares
|
+$200,000 | 17 Apr 2026 |
| STROME INVESTMENT MANAGEMENT LP |
3/4/5
Affiliate of 10% Owner
|
—
class O/S missing
|
$1,145,884
572,942 shares
|
+$200,000 | 17 Apr 2026 |
| Nola E. Masterson |
3/4/5
Director
|
—
class O/S missing
|
$2,642,992
130,906 shares
|
— | 01 Jan 2025 |
| Alison A. Cornell |
3/4/5
Director
|
—
mixed-class rows
|
$2,399,241
280,704 shares
mixed-class rows
|
+$99,995 | 26 Jan 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to buying over the last 12 months. Net value: +$1,889,771.
Buys
$1,889,771
Insiders: 7
Sells
$0
Insiders: 0
Net
+$1,889,771
Shares: +414,626
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 414,626
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 323,977 | 0 | $835,395 | $0 | +$835,395 |
| 6-9 | 29,727 | 0 | $254,969 | $0 | +$254,969 |
| 9-12 | 60,922 | 0 | $799,407 | $0 | +$799,407 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-11 of 11 reporting-owner rows connected to Zivo Bioscience, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
11
Largest Forms 3/4/5 holder
Laith L. Yaldoo
Net 12M change
+$1,889,771
Latest report
17 Apr 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Laith L. Yaldoo | Director, 10%+ Owner | $5,687,168 | +$344,971 | +6.5% | Mixed | 27 Feb 2026 |
| Christopher D. Maggiore | Director, 10%+ Owner | $4,419,754 | +$299,414 | +7.3% | Mixed | 14 Jan 2026 |
| Nola E. Masterson | Director | $2,642,992 | Mixed | 01 Jan 2025 | ||
| Alison A. Cornell | Director | $2,399,241 | +$99,995 | +4.3% | Mixed | 26 Jan 2026 |
| STROME INVESTMENT MANAGEMENT LP | Affiliate of 10% Owner | $1,145,884 | +$200,000 | +21% | Filing P/S | 17 Apr 2026 |
| Mark E. Strome | 10%+ Owner | $1,145,884 | +$645,396 | +129% | Filing P/S | 17 Apr 2026 |
| STROME GROUP, INC. | Affiliate of 10% Owner | $1,145,884 | +$200,000 | +21% | Filing P/S | 17 Apr 2026 |
| John B. Payne | President and CEO, Director | $167,537 | +$99,995 | +148% | Filing P/S | 26 Jan 2026 |
| William A. Sullivan | Chief Financial Officer | Mixed | 19 Dec 2025 | |||
| Keith Marchiando | Chief Financial Officer | Mixed | 05 Jun 2024 | |||
| Andrew A. Dahl | President / CEO, Director | Mixed | 21 Oct 2021 |
Recent insider transactions for Zivo Bioscience, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Strome Mark E | ZIVO | Common Stock | Purchase | 21.1% | $200,000 | $2.00 | 100,000 | 572,942 | 17 Apr 2026 | By entity |
| Strome Mark E | ZIVO | Common Stock | Purchase | 21.1% | $200,000 | $2.00 | 100,000 | 572,942 | 17 Apr 2026 | By entity |
| Mark E. Strome | ZIVO | Common Stock | Purchase | 21.1% | $200,000 | $2.00 | 100,000 | 572,942 | 17 Apr 2026 | By entity |
| Laith L. Yaldoo | ZIVO | Common Stock | Purchase | 0.27% | $14,998 | $9.72 | 1,543 | 583,615 | 27 Feb 2026 | HEP Investment, LLC |
| Mark E. Strome | ZIVO | Common Stock | Purchase | 4.42% | $195,400 | $9.77 | 20,000 | 472,942 | 12 Feb 2026 | By entity |
| Mark E. Strome | ZIVO | Common Stock Purchase Warrant | Purchase | 4.64% | 2,000 | 45,071 | 12 Feb 2026 | By entity | ||
| Laith L. Yaldoo | ZIVO | Common Stock | Purchase | 0.42% | $24,997 | $10.27 | 2,434 | 582,072 | 10 Feb 2026 | HEP Investments LLC |
| Alison A. Cornell | ZIVO | Common Stock | Purchase | 4.37% | $99,995 | $8.54 | 11,709 | 279,481 | 26 Jan 2026 | Direct |
| John B. Payne | ZIVO | Common Stock | Purchase | 148% | $99,995 | $8.54 | 11,709 | 19,618 | 26 Jan 2026 | Direct |
| Christopher D. Maggiore | ZIVO | Common Stock | Purchase | 0.34% | $14,993 | $8.49 | 1,766 | 519,292 | 14 Jan 2026 | Direct |
| Laith L. Yaldoo | ZIVO | Common Stock | Purchase | 0.31% | $14,993 | $8.49 | 1,766 | 579,638 | 14 Jan 2026 | by HEP Investments LLC |
| Laith L. Yaldoo | ZIVO | Common Stock | Purchase | 0.48% | $24,993 | $9.00 | 2,777 | 577,872 | 28 Nov 2025 | by HEP Investments LLC |
| Mark E. Strome | ZIVO | Common Stock | Purchase | 4.68% | $249,996 | $12.34 | 20,259 | 452,942 | 13 Oct 2025 | By entity |
| Mark E. Strome | ZIVO | Common Stock Purchase Warrant | Purchase | 4.93% | 2,025 | 43,071 | 13 Oct 2025 | By entity | ||
| Laith L. Yaldoo | ZIVO | Common Stock | Purchase | 0.29% | $19,991 | $12.05 | 1,659 | 575,095 | 10 Oct 2025 | by HEP Investments LLC |
| Christopher D. Maggiore | ZIVO | Common Stock | Purchase | 4.8% | $284,421 | $12.01 | 23,682 | 517,526 | 08 Oct 2025 | Direct |
| Laith L. Yaldoo | ZIVO | Nonstatutory Stock Options to buy Common Stock | Award | 926 | 926 | 02 Oct 2025 | Direct | |||
| Christopher D. Maggiore | ZIVO | Nonstatutory Stock Options to buy Common Stock | Award | 1,075 | 1,075 | 02 Oct 2025 | Direct | |||
| Alison A. Cornell | ZIVO | Nonstatutory Stock Options to buy Common Stock | Award | 1,223 | 1,223 | 02 Oct 2025 | Direct | |||
| Laith L. Yaldoo | ZIVO | Common Stock | Purchase | 2.75% | $244,999 | $15.99 | 15,322 | 573,436 | 30 Sep 2025 | by HEP Investments LLC |
* marks a reported price that did not pass the local price check.